Latest Healthcare Research Reports

Tag: ivd raw materials market forecast

  • IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    IVD Raw Materials Market Forecast: What Market Value Is Expected By 2030?

    The market for in vitro diagnostic raw materials has experienced robust expansion recently. Projections indicate a rise from $27.47 billion in 2025 to $30.16 billion in 2026, reflecting a compound annual growth rate of 9.8%. This upward trajectory in the historical period has been fueled by several key factors, including a greater volume of clinical diagnostic tests being performed, a higher uptake of immunoassay technologies, the broader application of molecular diagnostics, an increasing need for detecting diseases at early stages, and the well-established use of enzymes and antibodies within in vitro diagnostic kits.

    The market for in-vitro diagnostic (IVD) raw materials is poised for substantial expansion in the upcoming years, projecting a reach of $43.76 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.8%. This anticipated growth trajectory over the forecast period is largely propelled by several key factors including the escalating incidence of both chronic and infectious diseases, augmented investments aimed at enhancing precision diagnostics, the expanding utilization of point-of-care testing solutions, a surge in biopharmaceutical research and development endeavors, and a discernible increase in the demand for bespoke IVD raw materials. Significant market trends anticipated within this timeframe encompass a heightened demand for diagnostic reagents characterized by exceptional purity levels, an increasing embrace of recombinant antibodies and proteins in IVD manufacturing, a broader application of materials for molecular diagnostics, a heightened emphasis on ensuring superior quality and consistent batch production, and strategic efforts toward diversifying the supply chain for essential IVD components.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    IVD Raw Materials Market Demand Drivers: What Is Fueling Industry Growth?

    The expanding incidence of infectious diseases is poised to be a significant catalyst for the advancement of the IVD raw materials market. Infectious diseases, defined as ailments stemming from pathogenic microorganisms capable of transmission between individuals or other life forms, are becoming more widespread due to accelerating urbanization. This urban growth exacerbates disease transmission through heightened population density and places considerable strain on existing sanitation systems and healthcare facilities. Crucially, the components used in in-vitro diagnostics are instrumental in the fight against infectious diseases, facilitating the creation of precise diagnostic tools essential for early identification and proficient disease control. A notable illustration of this trend, as reported by the Centers for Disease Control and Prevention in March 2024, is the increase in tuberculosis cases within the United States, climbing from 8,320 in 2022 to 9,615 in 2023, marking an escalation of 1,295 instances. Consequently, the escalating rate of infectious diseases directly fuels the expansion of the IVD raw materials sector.

    IVD Raw Materials Market Segments: Where Are The Largest Growth Opportunities?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    IVD Raw Materials Market Innovation Trends: Which Developments Are Transforming The Industry?

    In the realm of In Vitro Diagnostic (IVD) raw materials, leading corporations are channeling efforts into pioneering sophisticated offerings, specifically IVD production plants, with the dual aims of bolstering local diagnostic capacities and fostering healthcare autonomy. An IVD production facility is engineered for the conception, fabrication, and rigorous quality assurance of diagnostic tools and apparatus employed in analyzing bodily samples ex vivo to identify ailments and health states. Illustrating this trend, in January of 2024, Colexa Biosensor Limited, a Nigerian health innovation firm, joined forces with Codix Pharma Limited, a fellow Nigerian pharmaceutical entity, to inaugurate the inaugural in vitro diagnostics manufacturing establishment in Sub-Saharan Africa, situated in Lagos. This venture, responsible for manufacturing the onpoint blood glucose meter and accompanying strips, marks a pivotal advancement for healthcare across the African continent, specifically targeting the escalating incidence of diabetes and enhancing the accessibility of diagnostic services. The plant possesses an initial production output of 3.6 million units per annum, with a scalable capacity reaching up to 10.8 million units, and its immediate strategic objective is to satisfy the diagnostic needs within West Africa.

    IVD Raw Materials Market Major Participants And Competitive Dynamics

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Access The Complete IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    IVD Raw Materials Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the IVD raw materials market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    IVD Raw Materials Market Forecast: What Market Value Is Expected By 2030?

    The market for in vitro diagnostic raw materials has experienced robust expansion recently. Projections indicate a rise from $27.47 billion in 2025 to $30.16 billion in 2026, reflecting a compound annual growth rate of 9.8%. This upward trajectory in the historical period has been fueled by several key factors, including a greater volume of clinical diagnostic tests being performed, a higher uptake of immunoassay technologies, the broader application of molecular diagnostics, an increasing need for detecting diseases at early stages, and the well-established use of enzymes and antibodies within in vitro diagnostic kits.

    The market for in-vitro diagnostic (IVD) raw materials is poised for substantial expansion in the upcoming years, projecting a reach of $43.76 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.8%. This anticipated growth trajectory over the forecast period is largely propelled by several key factors including the escalating incidence of both chronic and infectious diseases, augmented investments aimed at enhancing precision diagnostics, the expanding utilization of point-of-care testing solutions, a surge in biopharmaceutical research and development endeavors, and a discernible increase in the demand for bespoke IVD raw materials. Significant market trends anticipated within this timeframe encompass a heightened demand for diagnostic reagents characterized by exceptional purity levels, an increasing embrace of recombinant antibodies and proteins in IVD manufacturing, a broader application of materials for molecular diagnostics, a heightened emphasis on ensuring superior quality and consistent batch production, and strategic efforts toward diversifying the supply chain for essential IVD components.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    IVD Raw Materials Market Demand Drivers: What Is Fueling Industry Growth?

    The expanding incidence of infectious diseases is poised to be a significant catalyst for the advancement of the IVD raw materials market. Infectious diseases, defined as ailments stemming from pathogenic microorganisms capable of transmission between individuals or other life forms, are becoming more widespread due to accelerating urbanization. This urban growth exacerbates disease transmission through heightened population density and places considerable strain on existing sanitation systems and healthcare facilities. Crucially, the components used in in-vitro diagnostics are instrumental in the fight against infectious diseases, facilitating the creation of precise diagnostic tools essential for early identification and proficient disease control. A notable illustration of this trend, as reported by the Centers for Disease Control and Prevention in March 2024, is the increase in tuberculosis cases within the United States, climbing from 8,320 in 2022 to 9,615 in 2023, marking an escalation of 1,295 instances. Consequently, the escalating rate of infectious diseases directly fuels the expansion of the IVD raw materials sector.

    IVD Raw Materials Market Segments: Where Are The Largest Growth Opportunities?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    IVD Raw Materials Market Innovation Trends: Which Developments Are Transforming The Industry?

    In the realm of In Vitro Diagnostic (IVD) raw materials, leading corporations are channeling efforts into pioneering sophisticated offerings, specifically IVD production plants, with the dual aims of bolstering local diagnostic capacities and fostering healthcare autonomy. An IVD production facility is engineered for the conception, fabrication, and rigorous quality assurance of diagnostic tools and apparatus employed in analyzing bodily samples ex vivo to identify ailments and health states. Illustrating this trend, in January of 2024, Colexa Biosensor Limited, a Nigerian health innovation firm, joined forces with Codix Pharma Limited, a fellow Nigerian pharmaceutical entity, to inaugurate the inaugural in vitro diagnostics manufacturing establishment in Sub-Saharan Africa, situated in Lagos. This venture, responsible for manufacturing the onpoint blood glucose meter and accompanying strips, marks a pivotal advancement for healthcare across the African continent, specifically targeting the escalating incidence of diabetes and enhancing the accessibility of diagnostic services. The plant possesses an initial production output of 3.6 million units per annum, with a scalable capacity reaching up to 10.8 million units, and its immediate strategic objective is to satisfy the diagnostic needs within West Africa.

    IVD Raw Materials Market Major Participants And Competitive Dynamics

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Access The Complete IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    IVD Raw Materials Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the IVD raw materials market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    IVD Raw Materials Market Expansion Is Opening New Pathways For Strategic Investment

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    IVD Raw Materials Market Forecast: What Market Value Is Expected By 2030?

    The market for in vitro diagnostic raw materials has experienced robust expansion recently. Projections indicate a rise from $27.47 billion in 2025 to $30.16 billion in 2026, reflecting a compound annual growth rate of 9.8%. This upward trajectory in the historical period has been fueled by several key factors, including a greater volume of clinical diagnostic tests being performed, a higher uptake of immunoassay technologies, the broader application of molecular diagnostics, an increasing need for detecting diseases at early stages, and the well-established use of enzymes and antibodies within in vitro diagnostic kits.

    The market for in-vitro diagnostic (IVD) raw materials is poised for substantial expansion in the upcoming years, projecting a reach of $43.76 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.8%. This anticipated growth trajectory over the forecast period is largely propelled by several key factors including the escalating incidence of both chronic and infectious diseases, augmented investments aimed at enhancing precision diagnostics, the expanding utilization of point-of-care testing solutions, a surge in biopharmaceutical research and development endeavors, and a discernible increase in the demand for bespoke IVD raw materials. Significant market trends anticipated within this timeframe encompass a heightened demand for diagnostic reagents characterized by exceptional purity levels, an increasing embrace of recombinant antibodies and proteins in IVD manufacturing, a broader application of materials for molecular diagnostics, a heightened emphasis on ensuring superior quality and consistent batch production, and strategic efforts toward diversifying the supply chain for essential IVD components.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    IVD Raw Materials Market Demand Drivers: What Is Fueling Industry Growth?

    The expanding incidence of infectious diseases is poised to be a significant catalyst for the advancement of the IVD raw materials market. Infectious diseases, defined as ailments stemming from pathogenic microorganisms capable of transmission between individuals or other life forms, are becoming more widespread due to accelerating urbanization. This urban growth exacerbates disease transmission through heightened population density and places considerable strain on existing sanitation systems and healthcare facilities. Crucially, the components used in in-vitro diagnostics are instrumental in the fight against infectious diseases, facilitating the creation of precise diagnostic tools essential for early identification and proficient disease control. A notable illustration of this trend, as reported by the Centers for Disease Control and Prevention in March 2024, is the increase in tuberculosis cases within the United States, climbing from 8,320 in 2022 to 9,615 in 2023, marking an escalation of 1,295 instances. Consequently, the escalating rate of infectious diseases directly fuels the expansion of the IVD raw materials sector.

    IVD Raw Materials Market Segments: Where Are The Largest Growth Opportunities?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    IVD Raw Materials Market Innovation Trends: Which Developments Are Transforming The Industry?

    In the realm of In Vitro Diagnostic (IVD) raw materials, leading corporations are channeling efforts into pioneering sophisticated offerings, specifically IVD production plants, with the dual aims of bolstering local diagnostic capacities and fostering healthcare autonomy. An IVD production facility is engineered for the conception, fabrication, and rigorous quality assurance of diagnostic tools and apparatus employed in analyzing bodily samples ex vivo to identify ailments and health states. Illustrating this trend, in January of 2024, Colexa Biosensor Limited, a Nigerian health innovation firm, joined forces with Codix Pharma Limited, a fellow Nigerian pharmaceutical entity, to inaugurate the inaugural in vitro diagnostics manufacturing establishment in Sub-Saharan Africa, situated in Lagos. This venture, responsible for manufacturing the onpoint blood glucose meter and accompanying strips, marks a pivotal advancement for healthcare across the African continent, specifically targeting the escalating incidence of diabetes and enhancing the accessibility of diagnostic services. The plant possesses an initial production output of 3.6 million units per annum, with a scalable capacity reaching up to 10.8 million units, and its immediate strategic objective is to satisfy the diagnostic needs within West Africa.

    IVD Raw Materials Market Major Participants And Competitive Dynamics

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Access The Complete IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    IVD Raw Materials Market Leading Geography: Which Region Generates The Most Revenue?

    North Americawas the largest region in the IVD raw materials market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • IVD Raw Materials Market Revenue Anticipated To Reach $43.76 Billion By 2030 With 9.8% CAGR

    IVD Raw Materials Market Revenue Anticipated To Reach $43.76 Billion By 2030 With 9.8% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Will Be The Estimated Market Size Of The IVD Raw Materials Market By 2030?

    The ivd raw materials market has demonstrated substantial expansion in recent years. This market is projected to expand from $27.47 billion in 2025 to $30.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. Historically, this growth was propelled by factors such as the increase in clinical diagnostic testing volumes, the growing acceptance of immunoassays, the broadening of molecular diagnostics, a heightened demand for early disease detection, and the established application of enzymes and antibodies within ivd kits.

    The ivd raw materials market is projected to experience robust expansion in the coming years, set to reach $43.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.8%. Factors driving this growth during the forecast period include the increasing incidence of chronic and infectious diseases, greater investment in precision diagnostics, the expansion of point-of-care testing, burgeoning biopharmaceutical R&D efforts, and a growing need for tailored ivd raw materials. Key trends anticipated for this period encompass a heightened demand for high-purity diagnostic reagents, the increasing embrace of recombinant antibodies and proteins, broader application of molecular diagnostics raw materials, a stronger emphasis on quality and batch consistency, and the diversification of supply chains for essential ivd inputs.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    What Market Drivers Are Helping Shape The IVD Raw Materials Market Expansion?

    The future expansion of the IVD raw materials market is anticipated to be fueled by the rising occurrence of infectious diseases. These diseases are health conditions stemming from detrimental microorganisms capable of transmission between individuals or organisms. This growing incidence of infectious diseases is linked to swift urbanization, a factor that exacerbates their spread through higher population concentrations and by placing pressure on sanitation and healthcare systems. IVD raw materials are vital in confronting infectious diseases, as they facilitate the creation of precise diagnostic tools essential for prompt identification and efficient management of these conditions. For example, data from March 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency, revealed an escalation in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the expanding occurrence of infectious diseases is a primary catalyst for the development of the IVD raw materials market.

    How Is Segment Classification Applied In The IVD Raw Materials Market?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    What Trends Are Shaping The IVD Raw Materials Market Structure?

    Companies operating within the IVD raw materials market are directing their efforts towards developing advanced solutions, including IVD manufacturing facilities, with the aim of strengthening regional diagnostic capabilities and supporting healthcare self-sufficiency. An IVD manufacturing facility is a specialized establishment where devices and equipment utilized for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and subjected to quality and compliance testing. As an illustration, in January 2024, Colexa Biosensor Limited, a health technology company based in Nigeria, partnered with Codix Pharma Limited, a Nigerian pharmaceutical manufacturing company, to launch Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, responsible for producing the onpoint blood glucose meter and strips, represents a significant milestone in Africa’s healthcare industry, specifically designed to address the rising diabetes prevalence and improve diagnostic access. The facility possesses an annual production capacity of 3.6 million packs, with the capacity for expansion to 10.8 million packs, initially prioritizing the fulfillment of demands across West Africa.

    Which Companies Form The Competitive Landscape Of The IVD Raw Materials Market?

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Access The Complete IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Which Region Accounts For The Highest Share Of The IVD Raw Materials Market?

    North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access IVD Raw Materials Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    Browse Through More Reports Similar to the Global IVD Raw Materials Market 2026, By The Business Research Company

    Medical Engineered Materials Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

    International Wholesale Voice Carrier Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/international-wholesale-voice-carrier-global-market-report

    Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • IVD raw materials market outlook 2026–2030 highlighting key trends

    IVD raw materials market outlook 2026–2030 highlighting key trends

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Growth In Market Value Is Expected For The IVD Raw Materials Market Between 2026 And 2030?

    The ivd raw materials market size has shown robust expansion in recent years. It is forecast to rise from $27.47 billion in 2025 to $30.16 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. This historical growth can be linked to several factors, including an increase in clinical diagnostic testing volumes, the rising adoption of immunoassays, the ongoing expansion of molecular diagnostics, a greater demand for early disease detection, and the widespread application of enzymes and antibodies in ivd kits.

    The ivd raw materials market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $43.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.8%. The drivers for this growth during the forecast period include an escalating prevalence of chronic and infectious diseases, increased capital expenditure in precision diagnostics, the expansion of point-of-care testing, broader biopharmaceutical research and development activities, and a greater need for tailored ivd raw materials. Key trends expected during the forecast timeframe encompass an increasing requirement for high-purity diagnostic reagents, wider acceptance of recombinant antibodies and proteins, the extended use of raw materials for molecular diagnostics, a heightened emphasis on quality and consistency across batches, and the diversification of supply chains for essential ivd components.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    Which Key Drivers Are Affecting The IVD Raw Materials Market Development?

    The **IVD raw materials market** is anticipated to expand due to the rising occurrence of infectious diseases, which are conditions resulting from detrimental microorganisms capable of transmission between individuals or organisms. This growing prevalence stems from swift urbanization, fostering disease spread by boosting population density and overtaxing sanitation and healthcare facilities. **IVD raw materials** are vital in combating such diseases as they facilitate the creation of precise diagnostic tools for timely detection and efficient disease control. A notable example is the increase in **tuberculosis cases** reported by the **Centers for Disease Control and Prevention**, a **US-based government agency**, in **March 2024**, where numbers rose from **8,320 in 2022** to **9,615 in 2023**, marking a **rise of 1,295 cases**. Consequently, the escalating incidence of infectious diseases is a key driver for the growth of the **IVD raw materials market**.

    How Is The IVD Raw Materials Market Categorized Across Its Segment Groups?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    What Trends Are Transforming The IVD Raw Materials Market?

    Major companies operating in the IVD raw materials market are focusing on developing advanced solutions, such as IVD manufacturing facilities, to strengthen regional diagnostic capabilities and support healthcare self-sufficiency. An in vitro diagnostic (IVD) manufacturing facility is a specialized site where devices and equipment used for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, partnered with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to launch Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, which produces the onpoint blood glucose meter and strips, is a significant milestone in Africa’s healthcare industry, designed to address the rising diabetes prevalence and improve diagnostic access. The facility can produce 3.6 million packs annually, with the potential for expansion to 10.8 million packs, focusing initially on meeting the demands of West Africa.

    Which Firms Are Influencing Competition In The IVD Raw Materials Market?

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Get The Full IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Where Is The IVD Raw Materials Market Most Concentrated Geographically?

    North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized IVD Raw Materials Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Browse Through More Reports Similar to the Global IVD Raw Materials Market 2026, By The Business Research Company

    Medical Engineered Materials Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

    International Wholesale Voice Carrier Market Report

    https://www.thebusinessresearchcompany.com/report/international-wholesale-voice-carrier-global-market-report

    Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report

    https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global IVD Raw Materials Industry Insights: Key Trends and Growth Estimates

    Global IVD Raw Materials Industry Insights: Key Trends and Growth Estimates

    Uncover key drivers, emerging technologies, and competitive movements shaping the ivd raw materials market from 2026–2035 with trusted insights from The Business Research Company

    How much larger will the IVD Raw Materials Market be in 2030 compared with 2026?

    The ivd raw materials market has observed substantial growth in recent times. Its value is anticipated to climb from $27.47 billion in 2025 to $30.16 billion by 2026, progressing at a compound annual growth rate (CAGR) of 9.8%. The historical expansion of this market can be linked to factors such as increased volumes in clinical diagnostic testing, the growing adoption of immunoassays, the widening reach of molecular diagnostics, an escalating demand for early disease detection, and the well-established utilization of enzymes and antibodies within ivd kits.

    The ivd raw materials market size is anticipated to experience significant growth in the upcoming years. It is projected to expand to $43.76 billion by 2030, with a compound annual growth rate (CAGR) of 9.8%. This growth throughout the forecast period stems from factors such as the increasing prevalence of chronic and infectious diseases, greater investment in precision diagnostics, the expansion of point-of-care testing, broadening biopharmaceutical research and development activities, and a rising need for customized ivd raw materials. Significant trends during the forecast period involve an escalating demand for high-purity diagnostic reagents, the increasing adoption of recombinant antibodies and proteins, a wider application of molecular diagnostics raw materials, a heightened focus on quality and batch consistency, and the diversification of supply chains for critical ivd inputs.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    What Drivers Are Guiding Growth Patterns In The IVD Raw Materials Market?

    The rising occurrence of infectious diseases is projected to drive expansion within the IVD raw materials market in the foreseeable future. These diseases refer to sicknesses caused by detrimental microorganisms capable of transmission between individuals or organisms. The growing incidence of infectious diseases stems from swift urbanization, which fosters their spread by heightening population density and putting pressure on sanitation and healthcare systems. IVD raw materials are vital in confronting infectious diseases, as they facilitate the creation of precise diagnostic tools essential for prompt identification and efficient management of these conditions. For example, data from March 2024, provided by the US-based government agency, the Centers for Disease Control and Prevention, showed a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the escalating occurrence of infectious diseases is fueling the expansion of the IVD raw materials market.

    How Is The IVD Raw Materials Market Divided Into Segments?

    The ivd raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

    3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    What Trends Are Reshaping The Dynamics Of The IVD Raw Materials Market?

    Major companies operating in the IVD raw materials market are concentrating on developing advanced solutions, such as IVD manufacturing facilities, to bolster regional diagnostic capabilities and support healthcare self-sufficiency. An IVD (in vitro diagnostic) manufacturing facility is a specialized site where devices and equipment used for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and rigorously tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, joined forces with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to inaugurate Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, which manufactures the onpoint blood glucose meter and strips, marks a significant achievement in Africa’s healthcare industry, aimed at addressing the increasing diabetes prevalence and improving diagnostic accessibility. The facility has an annual production capacity of 3.6 million packs, with the potential for expansion to 10.8 million packs, initially prioritizing the demands of West Africa.

    Which Major Industry Participants Are Leading The IVD Raw Materials Market Growth?

    Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Which Geographic Areas Are Emerging As Strong Markets For The IVD Raw Materials Market?

    North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized IVD Raw Materials Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    Browse Through More Reports Similar to the Global IVD Raw Materials Market 2026, By The Business Research Company

    Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026

    https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

    Medical Engineered Materials Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

    International Wholesale Voice Carrier Market Report 2026

    https://www.thebusinessresearchcompany.com/report/international-wholesale-voice-carrier-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Factors Will Push The IVD Raw Materials Market To Achieve $39.88 Billion By 2029?

    Which Factors Will Push The IVD Raw Materials Market To Achieve $39.88 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Present And Forecasted Size Of The IVD Raw Materials Market?

    The market size for ivd raw materials has notably expanded in the past few years. It is projected to progress from $25.13 billion in 2024 to $27.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.3%. The historic growth has been driven by factors such as augmenting instances of infectious and chronic diseases, an escalated demand for lab-based diagnostic testing, a surge in the use of enzyme and protein-based reagents for diagnostics, the expansion of clinical diagnostic labs, and an increase in awareness and initiatives for early disease detection.

    Expectations for the ivd raw materials market project a robust expansion in the upcoming years with a projected value of $39.88 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.8%. This significant increase is due largely to factors such as a surge in demand for rapid and highly sensitive diagnostic solutions, the widening application of molecular diagnostics in the field of oncology, an aging global population and the correspondingly increasing burden of disease, a rise in demand for companion diagnostics, and escalated investment from biopharmaceutical firms. Key market trends to watch for in this period include a shift towards recombinant and synthetic raw materials, the integration of multiplex assays that necessitate specialized materials, an uptick in demand for lyophilized and ready-to-use reagent formats, and the manufacture of raw materials designed to fit microfluidic and lab-on-a-chip systems.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    What Underlying Factors Are Supporting The IVD Raw Materials Market Growth?

    The anticipated growth of the IVD raw materials market is largely due to the rising incidence of infectious diseases. Infectious diseases, caused by damaging microbes that can be transmitted from person to person or organism to organism, are becoming more prevalent due to expanding urbanization. This urban growth contributes to the spread of these diseases by heightening population density and placing additional pressure on sanitation and healthcare systems. IVD raw materials are essential in the fight against infectious diseases, as they facilitate the creation of precise diagnostic tests for early detection and efficient disease treatment. For example, a 2023 report from the Statens Serum Institut, a medical laboratory in Denmark, revealed that there were 146 chronic hepatitis C cases in 2021, 72% (105 cases) of which were men, and by 2022, this figure had risen to 196 cases, 67% (131 cases) of which were men. This surge in infectious diseases supports the growth of the IVD raw materials market.

    How Does The IVD Raw Materials Market Differ By Segment?

    The ivd raw materialsmarket covered in this report is segmented –

    1) By Product: Antibodies; Antigens; Enzymes; Proteins; Biological Buffers; Other Products

    2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunochemistry; Other Technologies

    3) By End User: Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations; Other End Users

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies

    2) By Antigens: Recombinant Antigens; Native Antigens; Synthetic Antigens

    3) By Enzymes: Polymerases; Reverse Transcriptases; Oxidases

    4) By Proteins: Carrier Proteins; Blocking Proteins; Recombinant Proteins

    5) By Biological Buffers: Tris Buffers; HEPES Buffers; Phosphate Buffers

    6) By Other Products: Stabilizers; Surfactants; Preservatives

    What New Opportunities Are Emerging From Trends In The IVD Raw Materials Market?

    Leading firms in the IVD raw materials market are currently working to create innovative solutions, such as IVD production facilities. These efforts aim to enhance regional diagnostic abilities and promote self-sufficiency in healthcare. IVD manufacturing facilities are factories specializing in developing, manufacturing, and examining the quality of devices and equipment for disease diagnosis via lab testing of samples outside the human body. For example, in January 2024, Colexa Biosensor Limited, an Nigerian-based health tech firm, collaborated with Codix Pharma Limited, also headquartered in Nigeria, to introduce the very first in vitro diagnostics (IVD) manufacturing facility in Sub-Saharan Africa, located in Lagos. This facility primarily manufactures the onpoint blood glucose meter and strips, marking a significant step for Africa’s healthcare sector as it responds to growing diabetes rates and aims to enhance diagnostic accessibility. The facility has the capacity to produce 3.6 million packs per year, with a potential future expansion to 10.8 million packs. Its initial focus will be to meet the demands of West Africa.

    Who Are The Global Leaders Steering The IVD Raw Materials Market Forward?

    Major companies operating in the IVD raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Which Region Is Likely To Register The Fastest Growth In The IVD Raw Materials Market?

    North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    Browse Through More Reports Similar to the Global IVD Raw Materials Market 2025, By The Business Research Company

    In Vitro Diagnostics Ivd Quality Control Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

    Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

    Cardiac Biomarkers Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global IVD Raw Materials Market Overview: Trends Shaping Growth to 2029

    Global IVD Raw Materials Market Overview: Trends Shaping Growth to 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Market Value Is The IVD Raw Materials Industry Expected To Reach By 2029, Starting From 2025 Levels?

    The ivd raw materials market size has experienced significant expansion over recent years. It is projected to grow from $25.13 billion in 2024 to $27.47 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.3%. This historic growth can be attributed to the rising prevalence of infectious and chronic diseases, increased demand for laboratory-based diagnostic testing, broader application of enzyme- and protein-based reagents in diagnostics, the expansion of clinical diagnostic laboratories, and intensified efforts for awareness and early disease detection.

    The ivd raw materials market size is projected for substantial expansion in the coming years. This market is anticipated to reach $39.88 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.8%. This growth during the projection period can be attributed to factors such as increasing need for quick and highly sensitive diagnostic methods, broader use of molecular diagnostics in cancer treatment, an expanding elderly demographic along with associated health issues, rising call for companion diagnostics, and increased funding from biopharmaceutical firms. Key developments expected within this timeframe involve a move towards synthetic and recombinant raw ingredients, the incorporation of multiplex assays necessitating specific components, the widespread use of ready-to-use and lyophilized reagent forms, and the creation of raw materials specifically designed for microfluidic and lab-on-a-chip technologies.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    Which Drivers Are Shaping The IVD Raw Materials Industry’s Market Share?

    The rising occurrence of infectious diseases is anticipated to boost the expansion of the IVD raw materials market in the future. These diseases are conditions resulting from detrimental microbes capable of transmitting between individuals or organisms. This growing prevalence stems from rapid urbanization, which fosters the spread of infectious diseases through heightened population density and by putting pressure on sanitation and healthcare systems. IVD raw materials are vital in fighting infectious diseases, facilitating the creation of precise diagnostic tests for prompt identification and efficient disease control. For example, a report from May 2023 by the Statens Serum Institut, a medical laboratory based in Denmark, indicated that in 2021, 146 cases of chronic hepatitis C were documented, with 72% (105 cases) affecting men. By 2022, this figure rose to 196 cases, of which 67% (131 cases) were men. Consequently, the rising incidence of infectious diseases is stimulating the growth of the IVD raw materials market.

    What Are The Leading Segments Analyzed In The IVD Raw Materials Market?

    The ivd raw materialsmarket covered in this report is segmented –

    1) By Product: Antibodies; Antigens; Enzymes; Proteins; Biological Buffers; Other Products

    2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunochemistry; Other Technologies

    3) By End User: Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations; Other End Users

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies

    2) By Antigens: Recombinant Antigens; Native Antigens; Synthetic Antigens

    3) By Enzymes: Polymerases; Reverse Transcriptases; Oxidases

    4) By Proteins: Carrier Proteins; Blocking Proteins; Recombinant Proteins

    5) By Biological Buffers: Tris Buffers; HEPES Buffers; Phosphate Buffers

    6) By Other Products: Stabilizers; Surfactants; Preservatives

    What Are The Major Trends Driving The Growth Of The IVD Raw Materials Market?

    Major entities operating within the IVD raw materials market are concentrating on developing sophisticated solutions, such as IVD manufacturing facilities, to enhance regional diagnostic capabilities and promote healthcare self-sufficiency. An IVD (in vitro diagnostic) manufacturing facility is a specialized center where devices and equipment for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, manufactured, and assessed for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology firm, partnered with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to launch Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This establishment, which produces the onpoint blood glucose meter and strips, represents a significant achievement in Africa’s healthcare industry, designed to address the growing prevalence of diabetes and improve access to diagnostics. The facility currently has an annual production capacity of 3.6 million packs, with the potential to expand to 10.8 million packs, initially focusing on fulfilling the demands of West Africa.

    Which Major Firms Are Strengthening Their Position In The IVD Raw Materials Industry?

    Major companies operating in the IVD raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    Which Region Is Expected To Witness The Fastest Growth In The IVD Raw Materials Market?

    North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The IVD Raw Materials Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    Browse Through More Reports Similar to the Global IVD Raw Materials Market 2025, By The Business Research Company

    In Vitro Diagnostics Ivd Quality Control Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

    Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

    Cardiac Biomarkers Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Strategic Growth Drivers Shaping the IVD Raw Materials Market Outlook 2025- 2034:Surge In Infectious Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Urbanization

    Strategic Growth Drivers Shaping the IVD Raw Materials Market Outlook 2025- 2034:Surge In Infectious Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Urbanization

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Key Milestones in the IVD Raw Materials Market’s Growth Trajectory From 2025 To 2034?

    The market size of ivd raw materials has witnessed robust growth in the past few years. It is projected to escalate from $25.13 billion in 2024 to $27.47 billion in 2025, realizing a compound annual growth rate (CAGR) of 9.3%. The observed growth during the historical time frame can be linked to the increasing occurrence of infectious and chronic diseases, a surge in the need for laboratory-based diagnostic testing, a rise in the utilization of enzyme- and protein-based reagents in diagnostics, growth of clinical diagnostic laboratories, and heightened awareness and efforts towards early disease detection.

    The market for ivd raw materials is set for robust expansion in the coming years, with projections indicating the market could reach $39.88 billion by 2029, experiencing a compound annual growth rate (CAGR) of 9.8%. This predicted expansion during the forecast period can be ascribed to several factors such as growing demand for quick and highly sensitive diagnostic services, broader use of molecular diagnostics in cancer treatment, rapidly expanding elderly population with corresponding increase in disease prevalence, elevated need for companion diagnostic services, and upsurge in investment from biopharmaceutical firms. Key market trends to watch during this period include a leaning towards recombinant and synthetic raw materials, combining of multiplex assays that necessitate specific materials, the rise in the use of lyophilized and ready-to-go reagent formats, and progress in developing raw materials specifically for microfluidic and lab-on-a-chip technologies.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    Which Factors and External Forces Are Driving Demand in the IVD Raw Materials Market?

    The growth of the IVD raw materials market is projected to be spurred by the rising occurrence of infectious diseases. Transmittable illnesses, caused by damaging microbes that can be passed from individual to individual or organism to organism, have been on the rise due to swift urbanization. This rapid urbanization aids in the spread of infectious diseases by boosting population density and putting pressure on sanitation and healthcare systems. IVD raw materials are instrumental in fighting these diseases by facilitating the creation of precise diagnostic tests that allow for early detection and efficient disease control. For instance, the Statens Serum Institut, a medical laboratory based in Denmark, reported in May 2023 that there were 146 chronic hepatitis C cases in 2021, with 72% (105 cases) involving men. This number rose to 196 cases in 2022, with 67% (131 cases) involving men. Consequently, the augmented occurrence of infectious diseases fuels the upward trend of the IVD raw materials market.

    Which Segments in the IVD Raw Materials Offer the Most Growth?

    The ivd raw materialsmarket covered in this report is segmented –

    1) By Product: Antibodies; Antigens; Enzymes; Proteins; Biological Buffers; Other Products

    2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunochemistry; Other Technologies

    3) By End User: Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations; Other End Users

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies

    2) By Antigens: Recombinant Antigens; Native Antigens; Synthetic Antigens

    3) By Enzymes: Polymerases; Reverse Transcriptases; Oxidases

    4) By Proteins: Carrier Proteins; Blocking Proteins; Recombinant Proteins

    5) By Biological Buffers: Tris Buffers; HEPES Buffers; Phosphate Buffers

    6) By Other Products: Stabilizers; Surfactants; Preservatives

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the IVD Raw Materials Market?# Market?

    North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Which Cutting-Edge Market Trends Are Expected to Drive theIVD Raw Materials Market’s Growth?

    Top firms in the IVD raw materials market are concentrating on creating innovative solutions, such as IVD production facilities, to enhance regional diagnostic capabilities and promote healthcare independence. An IVD manufacturing facility is a specialized place where devices and equipment used to diagnose diseases and conditions using lab tests on samples taken from the body are designed, manufactured, and tested for quality and conformity. For example, Colexa Biosensor Limited, a health tech firm based in Nigeria, teamed up with Codix Pharma Limited, a pharmaceutical manufacturer also in Nigeria, in January 2024 to initiate the first in vitro diagnostics manufacturing plant in Lagos, marking the first of its kind in Sub-Saharan Africa. The facility, producing the onpoint blood glucose meter and strips, represents a considerable milestone in Africa’s health sector, deliberately designed to respond to the escalating diabetes prevalence and ameliorate diagnostic reach. The facility can annually manufacture 3.6 million packs, with the potential to be expanded to 10.8 million packs, primarily targeting to fulfill the demands of West Africa initially.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    What Are the Key Elements That Define the IVD Raw Materials Market?

    In vitro diagnostics (IVD) raw materials refer to the fundamental biological and chemical substances required for the production and development of diagnostic assays that examine biological samples outside the human body. These materials are used to support the detection, measurement, or evaluation of analytes in clinical samples for diagnostic, screening, or monitoring purposes.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24270

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • IVD Raw Materials Market Size to Exceed $40.74 Billion by 2029 | Growth and Industry Trends

    IVD Raw Materials Market Size to Exceed $40.74 Billion by 2029 | Growth and Industry Trends

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the IVD Raw Materials Market Grown from 2024 to 2025?

    In recent times, there has been a marked acceleration in the growth of the IVD raw materials market. The market’s worth is expected to escalate from a value of $25.13 billion in 2024 to about $27.73 billion in 2025, indicative of a compound annual growth rate (CAGR) of 10.3%. The growth trajectory in the bygone period mirrors the increased incidence of infectious and chronic diseases, heightened demand for diagnostic testing based in laboratories, growing role of enzyme and protein-based reagents in diagnostics, proliferation of clinical laboratories for diagnostics, and bolstered efforts for disease awareness and early detection.

    What Growth Rate Is Anticipated for the IVD Raw Materials Market in the Coming Years?

    Over the coming years, the market size for IVD raw materials is forecasted to experience swift expansion. By 2029, it is predicted to reach a value of $40.74 billion, growing at a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this anticipated growth during the forecast period include increasing demand for efficient and highly sensitive diagnostic solutions, the expanding application of molecular diagnostics within oncology, a rising geriatric population with associated health conditions, growing demand for companion diagnostics, and rising investment from biopharmaceutical companies. Notable trends expected during the forecast period encompass a move towards synthetic and recombinant raw materials, incorporation of multiplex assays needing specialized materials, the use of lyophilized and ready-to-use reagent formats, and the production of raw materials specifically suited to microfluidic and lab-on-a-chip systems.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    Who Are the Leading Companies in the IVD Raw Materials Market?

    Major companies operating in the IVD raw materials market are F. Hoffmann-La Roche, Merck KGaA, Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company (BD), Agilent Technologies, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc.

    What Are the Key Drivers of the IVD Raw Materials Market?

    The escalation in the frequency of contagious diseases is forecasted to drive the expansion of the IVD raw materials market in the future. These are ailments triggered by detrimental microbes that can transfer from one individual or entity to another. The rise in such diseases can be attributed to accelerated urbanization, which promotes the spread of these diseases by intensifying population density and placing a serious strain on sanitation and healthcare facilities. IVD raw materials are pivotal in fighting against infectious diseases as they facilitate the creation of precise diagnostic tests, allowing for early recognition and effective disease control. For instance, a report published by the Denmark-based medical laboratory, Statens Serum Institut, in May 2023 revealed that in 2021, 146 cases of chronic hepatitis C were recorded, with 72% (105 cases) pertaining to men. However, in 2022, this number increased to 196 cases, with 67% (131 cases) comprising men. This surge in infectious diseases is hence fueling the growth of the IVD raw materials market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

    What Are the Key Market Segments in the IVD Raw Materials Industry?

    The IVD raw materials market covered in this report is segmented –

    1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers, Other Products

    2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Other Technologies

    3) By End User: Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Other End Users

    Subsegments:

    1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

    2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

    3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

    4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

    5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

    6) By Other Products: Stabilizers, Surfactants, Preservatives

    What Are the Latest Trends in the IVD Raw Materials Market?

    The key players in the IVD raw materials market are prioritizing the development of advanced solutions like IVD manufacturing facilities, in order to enhance regional diagnostic abilities and boost healthcare independence. An IVD manufacturing facility is a specialized place where devices and tools for diagnosing illnesses and conditions, through lab tests of samples outside the human body, are designed, created, and evaluated for quality and regulatory compliance. For instance, Colexa Biosensor Limited, a health technology firm based in Nigeria, teamed up with Codix Pharma Limited, a Nigerian pharmaceutical manufacturing company, to inaugurate the first-ever in vitro diagnostics manufacturing facility in Sub-Saharan Africa, located in Lagos, in January 2024. This facility, manufacturing onpoint blood glucose meter and strips, marks a significant achievement in the healthcare sector in Africa, conceived to tackle the increasing diabetes prevalence and enhance diagnostic access. It has the capacity to manufacture 3.6 million packs per year, with the scope to extend up to 10.8 million packs, primarily to fulfill the needs of West Africa.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

    What Are the Key Regional Markets in the IVD Raw Materials Industry?

    North America was the largest region in the IVD raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the IVD raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

    This Report Delivers Insight On:

    1. How big is the ivd raw materials market, and how is it changing globally?

    2. Who are the major companies in the ivd raw materials market, and how are they performing?

    3. What are the key opportunities and risks in the ivd raw materials market right now?

    4. Which products or customer segments are growing the most in the ivd raw materials market?

    5. What factors are helping or slowing down the growth of the ivd raw materials market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model